In 452 patients with nodal mature T-cell lymphoma in complete response after first-line therapy, relapse within 12 months (36.5%) was associated with worse overall survival (modified landmark HR 2.14), consistent in validation cohorts.
RCTn = 452 patients
Sorial et al. Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium